Autologous dendritic cells pulsed with prostatic acid phosphatase (APC8015) for patients with hormone-refractory prostate cancer with a Gleason score <or= 7

David Lee

doi:10.1016/S1540-0352(11)70024-5

$Autologous dendritic cells pulsed with prostatic acid phosphatase (APC8015) for patients with hormone-refractory prostate cancer with a Gleason score <or= 7$

Journal article

Autologous dendritic cells pulsed with prostatic acid phosphatase (APC8015) for patients with hormone-refractory prostate cancer with a Gleason score

David Lee

Clinical prostate cancer, Vol.2(2), pp.81-83

2003-09

DOI: https://doi.org/10.1016/S1540-0352(11)70024-5

PMID: 15040867

Abstract

Prostatic Neoplasms - pathology

Bone Neoplasms - therapy

Dendritic Cells - immunology

Humans

Middle Aged

Bone Neoplasms - secondary

Male

Treatment Outcome

Prostate-Specific Antigen - blood

Prostatic Neoplasms - therapy

Protein Tyrosine Phosphatases - immunology

Immunotherapy

Acid Phosphatase

Aged, 80 and over

Aged

Metrics

7 Record Views

Details

Title: Autologous dendritic cells pulsed with prostatic acid phosphatase (APC8015) for patients with hormone-refractory prostate cancer with a Gleason score
Creators: David Lee
Publication Details: Clinical prostate cancer, Vol.2(2), pp.81-83
Academic Unit: Miller School of Medicine; UMMG Department of Public Health Sciences Research
Language: English
Resource Type: Journal article
PMID: 15040867
Record Identifier: 991031600715102976